What is personalized immunotherapy?
Personalized immunotherapy uses the body's own immune system to target and destroy cancer cells, often tailored to an individual's specific genetic makeup or tumor profile.
Healthcare / Cancer
According to NHS England's outgoing national medical director, Professor Sir Stephen Powis, cancer treatment is entering a 'golden era.' Breakthroughs in understanding cancer genetics and the development of personalized immunotherapies are...
Professor Sir Stephen Powis's optimism is rooted in the progress of personalized immunotherapy and genetic testing. Personalized cancer vaccines, which train the body's immune system to kill cancer cells, are showing promise in treating skin, bowel, lung, brain, and pancreatic cancers. The NHS plans to administer these vaccines to up to 10,000 patients over the next five years.
Furthermore, DNA blood tests are now offered to lung and breast cancer patients to identify the genetic profiles of their tumors, enabling fast-tracked, personalized treatment plans. This individualization of treatment, driven by genetics, allows for more targeted and effective therapies.
However, challenges remain. Recent analysis indicates that nearly half of NHS trusts are failing to meet the target of treating 85% of cancer patients within two months of diagnosis. Addressing these service delivery gaps is crucial to ensure that the benefits of these treatment advances are accessible to all patients.
Personalized immunotherapy uses the body's own immune system to target and destroy cancer cells, often tailored to an individual's specific genetic makeup or tumor profile.
Improvements in care, including targeted drugs and immunotherapies, mean that one in two people now survive cancer for at least ten years, compared to one in four in the early 1970s.
Do you think this 'golden era' of cancer treatment will deliver on its promises? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.